Experienced, innovative biotech and pharma leader with demonstrated success in discovery and development of new therapeutic technologies  Amsterdam, NLD – 5 December 2023 – Kling Bio (“Kling” or “the Company”), a biotech company developing antibody-based drugs against targets identified from its immortalized B-cell platform, is pleased to announce the appointment of Dr Stefano Gullà as […]